Biontech bntx stock
WebApr 10, 2024 · 0. 3. 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00 ... WebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ...
Biontech bntx stock
Did you know?
WebApr 11, 2024 · According to the issued ratings of 13 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 7 hold ratings and 6 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $178.50 with a high price target of $260.00 and a low price target of $130.00. WebIs BioNTech SE (NASDAQ:BNTX) Trading At A 43% Discount? Key Insights The projected fair value for BioNTech is US$219 based on 2 Stage Free Cash Flow to Equity …
WebApr 6, 2024 · On Friday 03/31/2024 the closing price of the BioNTech (ADRs) share was $125.60 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of … WebBNTX Stock Summary. BNTX's current price/earnings ratio is 3.02, which is higher than merely 4.86% of US stocks with positive earnings. With a year-over-year growth in debt of -35.15%, BIONTECH SE's debt growth rate surpasses merely 8.03% of about US stocks.
WebBNTX Stock 12 Months Forecast $173.70 (34.76% Upside) Based on 11 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $173.70 with a high forecast of $260.00 and a low forecast of $130.00. The average price target represents a 34.76% change from the last price of $128.90. WebMar 31, 2024 · BioNTech SE Sponsored ADR (BNTX) closed at $124.57 in the latest trading session, marking a +1.63% move from the prior day. This change outpaced the S&P 500's 1.44% gain on the day.
WebBNTX Stock 12 Months Forecast. $173.70. (34.76% Upside) Based on 11 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The …
WebMar 28, 2024 · The net cost of a BioNTech takeover by a Big Pharma concern is far lower than you would think, with 50% of the current stock price backed by cash holdings. Longer term, if COVID refuses to go... high b1 foodsWebFounded. 2008. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, … high b1 food listWebApr 9, 2024 · BioNTech Stock Up 2.6 %. Shares of NASDAQ BNTX opened at $128.90 on Friday. The company has a current ratio of 7.43, a quick ratio of 7.28 and a debt-to-equity ratio of 0.01. BioNTech SE has a 12-month low of $117.08 and a 12-month high of $188.99. The firm’s 50-day moving average price is $133.36 and its 200-day moving average price … high b2 foodsWebMar 2, 2024 · Biopharmaceutical New Technologies or BioNTech ( NASDAQ: BNTX) is a large ($31 billion market cap) immunotherapy company. They are developing cancer product candidates (Figure 1) but known mostly ... high b2m microglobulinWebBNTX: BioNTech SE - Stock Price, Quote and News - CNBC BioNTech SE BNTX:NASDAQ EXPORT WATCHLIST + LIVE SQUAWK BOX RT Quote Last NYSE … high b6 in bloodWebApr 10, 2024 · Shares of BioNTech SE (NASDAQ:BNTX – Get Rating) have been given a consensus rating of “Hold” by the sixteen brokerages that are presently covering the stock, Marketbeat.com reports.Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target … high b6 icd10WebApr 8, 2024 · Systrade AG bought a new stake in BioNTech SE (NASDAQ:BNTX - Get Rating) during the fourth quarter, according to its most recent disclosure with the SEC.The firm bought 10,000 shares of the company's stock, valued at approximately $1,502,000. BioNTech comprises about 1.3% of Systrade AG's holdings, making the stock its 6th … how far is it from la to mexico border